Os 270 melhores médicos de ressonância magnética cerebral do mundo

O Dr. Park Sundo é especialista em cirurgia gastrointestinal e geral no Hospital Naeun. Sua experiência inclui cirurgia colorretal, proctológica, de mama, tireoide, laparoscópica, biliar, pancreática e pediátrica.

Os tratamentos principais incluem cirurgia proctológica, como hemorroidectomia e tratamento de hemorroidas e fístulas anais. Ele realiza cirurgia laparoscópica para cálculos biliares (colelitíase) e apendicite. Seu atendimento oncológico abrange câncer gástrico e colorretal. Ele também realiza reparo de hérnias. O cuidado com mamas e tireoide inclui tratamento de tumores e biópsia Mammotome. Ele trata varizes e queimaduras graves. A cirurgia pediátrica inclui reparo de hérnias e procedimentos pediátricos gerais.

O Dr. Tural Rajabov é neurocirurgião. Trata tumores cerebrais e da medula espinhal, traumatismos do SNC e hidrocefalia. Também realiza cirurgia endoscópica da base do crânio, cirurgia da coluna vertebral e cirurgia de nervos periféricos.

Formação: Universidade Médica Estatal de Tbilisi, Faculdade de Medicina (2010–2016). Internato em Neurocirurgia, Innova Medical Centre, Tbilisi (2016–2018). Residência em Neurocirurgia, Universidade Médica do Azerbaijão (2019–2024).

Afiliações profissionais: North American Skull Base Society (NASBS), European Association of Neurosurgical Societies (EANS) e a Associação de Neurocirurgiões do Azerbaijão (ANEA). Ele é afiliado ao Baku Medical Plaza Hospital em Baku, Azerbaijão.

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

O Dr. Tansu Gürsoy é especialista em neurocirurgia no Hospital Privado Optimed em Çerkezköy. Concluiu a sua formação no Hospital de Formação e Investigação de Ankara. A sua prática concentra-se na cirurgia da coluna vertebral. As áreas principais incluem escoliose degenerativa, hérnias discais, estenose espinal, traumatismos e tumores.

Em 2019, ganhou o terceiro lugar da Sociedade Turca de Neurocirurgia por um artigo sobre o pré-dobramento de hastes e parâmetros sagitais na escoliose degenerativa lombar. É coautor do Capítulo 75 (Classificação de Lenke-Silva e Escoliose Degenerativa em Adultos) no livro "The Aging Spine". A sua tese analisou o mau posicionamento de parafusos em 415 casos de fixação pedicular toracolombar.

É membro da Sociedade Turca de Neurocirurgia (Grupo de Cirurgia da Coluna e Nervos Periféricos), da Sociedade Turca da Coluna e da Associação Médica Turca. Concluiu o Curso Avançado de Cirurgia da Coluna e formação prática em anastomose microvascular e microcirurgia. Possui um Certificado de Categoria A para animais de experimentação. Também participa nos principais congressos de coluna.

O Dr. Erkan Göcen é especialista em Oncologia Radioterápica no Hospital Privado Çerkezköy Optimed (Optimed Health Group). Formou-se na Universidade de Istambul, Faculdade de Medicina (Çapa), em 2003.

Carreira: Treinou e praticou em Oncologia Radioterápica de 2010 a 2012. Trabalhou em instituições de saúde públicas e privadas de 2012 a 2016. Trabalhou no setor médico privado como especialista em Oncologia Radioterápica de 2016 a 2023. Está no Hospital Optimed desde 2024.

Interesses clínicos: cânceres de cérebro, cabeça e pescoço, esôfago, estômago, colorretal, pâncreas, próstata, bexiga, pulmão, tecidos moles (sarcomas), pele, útero e colo do útero, e mama. Afiliações: Sociedade Turca de Oncologia Radioterápica (TROD) e Câmara Médica de Tekirdağ. Idiomas: inglês e turco.

Prof. Dr. Hakan Levent Gül is a neurologist. He graduated from the Trakya University Faculty of Medicine in 1998. He completed his neurology residency at Dr. Lütfi Kırdar Kartal Training and Research Hospital. He later became an associate professor and then a professor. He also holds a second undergraduate degree in Healthcare Management.

He has worked as a neurologist and senior attending physician in public and private institutions. His expertise includes headache and dizziness, epilepsy, Parkinson’s disease, dementia, movement disorders, stroke, and sleep disorders. He provides neurological care at Moodist Hospital.

Dr. med. univ. Negar Fakhrai is a radiology specialist at JUVENIS Medical Center in Vienna. She performs diagnostic ultrasound. She has more than 20 years of experience in university, trauma, and private hospitals. She treats patients in German, English, Farsi, and French.

Education: MD, 2001. Her dissertation quantified coronary artery calcification with electron-beam computed tomography. Training in internal medicine and oncology at the Medical University of Vienna with CECOG (2001–2004). Radiology training at the University Clinic (2005–2013). Radiology specialist exam in 2010.

Career: Lorenz Böhler Trauma Hospital (2013–2021). Private clinics since 2016. Rudolfinerhaus (2021–2022). Independent since 2023, including Wiener Privatklinik. Joined JUVENIS in 03/2024. Strong focus on musculoskeletal imaging.

Awards/research: Investigator Award, University Clinic for Radiodiagnostics, Medical University of Vienna (2010). Publications in the American Journal of Neuroradiology, European Journal of Radiology, and Journal of Neuro-Oncology. Ultrasound: abdomen; vascular (carotids, deep leg veins); breast; thyroid/neck; muscles/joints; soft tissue; testes.

O Dr. Raanan Berger é o diretor do Centro de Câncer do Sheba Medical Center. Ele foi incluído na lista de "Melhores Médicos" da Forbes Israel em 2025. O Dr. Berger é especializado em oncologia geniturinária e trata tumores complexos de próstata com radioterapia. Ele completou um pós-doutorado no Dana-Farber/Harvard Cancer Institute.

• Chefia a unidade de pesquisa clínica focada em oncologia molecular.
• Coautor de mais de 20 artigos revisados por pares sobre câncer de próstata e mutações BRCA.
• Membro da Sociedade Americana de Oncologia Clínica (ASCO).
• Realiza terapia sistêmica e radioterapia em um hospital classificado entre os 10 melhores do mundo.

Assoc. Prof. Priv.-Doz. Dr. Alexander W. Hauswirth is a specialist in internal medicine and haemato‑oncology at JUVENIS. Since 2010, he has served as the lead senior physician for Haematology/Haemostaseology and Oncology at the Clinic for Internal Medicine I, Medical University of Vienna/AKH Vienna, Austria’s largest hospital.

He earned his medical degree from the University of Vienna in 1999. He received the venia docendi in 2010 and was appointed Associate Professor in 2012. He completed an additional haemato‑oncology qualification in 2014. As a Schrödinger Fellow in Salamanca in 2009–2010, he researched CLL stem and precursor cells. He has published regularly since 2000.

Accreditations include Austrian Medical Chamber diplomas in emergency medicine (since 2009) and sports medicine (2018). Awards include the Schrödinger Fellowship (2009), the ÖGHO award (2009), and the European Society of Chemotherapy poster award (2003). Clinical focus: anaemias, leukaemias, lymph node disorders, clotting and anticoagulation, and pre‑operative clearance. Languages: German and English.

O Dr. Yang Se Yeon é neurocirurgião e chefe do Departamento de Neurocirurgia do Hospital Naeun. Ele é especializado em infarto cerebral, hemorragia cerebral, aneurisma cerebral, doença de moyamoya, estenose da artéria carótida, tontura vascular e traumatismo craniano.

Ele se formou na Faculdade de Medicina da Universidade Católica da Coreia, onde também obteve um mestrado em Medicina. Concluiu o internato e a residência em neurocirurgia no Centro Médico Católico. Em seguida, completou uma bolsa clínica e atuou como professor clínico assistente no Hospital St. Mary de Uijeongbu.

Atuou como neurocirurgião no Centro Regional de Trauma de Gyeonggi do Norte. Também foi chefe de Neurocirurgia no Hospital G-SAM.

O Dr. Wutthiphong Wilaiwarangkun é um neurologista licenciado pelo Conselho Médico da Tailândia (licença ว.49590). Ele trabalha na Clínica Neuro Med, no Hospital Pacific Garden em Sriracha, Chonburi. Ele oferece consultas, diagnósticos e cuidados de longo prazo para distúrbios neurológicos.

Ele obteve seu diploma de medicina na Universidade Walailak. Ele possui o Diploma do Conselho Tailandês de Neurologia do Hospital Rajavithi, parte do Departamento de Serviços Médicos do Ministério da Saúde Pública. O Hospital Rajavithi é um centro de referência terciário credenciado. Ele gerencia um grande volume de casos de doenças cerebrovasculares, epilepsia, distúrbios neurodegenerativos e condições neuromusculares de toda a Tailândia.

Anteriormente, ele atuou como especialista em neurologia no Hospital Satun. Seu trabalho cobriu acidentes vasculares cerebrais agudos, neurologia de emergência e atendimento hospitalar e ambulatorial. Ele traz uma ampla experiência provincial para sua prática atual.

O Dr. Jair Bar é oncologista torácico e vice-diretor do Centro de Câncer do Sheba Medical Center. Ele é especializado no tratamento de câncer de pulmão de células não pequenas avançado usando imunoterapia personalizada e tratamentos direcionados. O Dr. Bar possui doutorado em Biologia Molecular e lidera um laboratório de pesquisa focado em resistência à imunoterapia.

• Presidente do Grupo Israelense de Câncer de Pulmão.
• Certificado em Oncologia Médica e Radioterapia Oncológica.
• Trata pacientes no Sheba Medical Center, um dos 10 melhores hospitais do mundo.
• Usa perfil molecular e genético para criar planos precisos de tratamento contra o câncer.

O Dr. Elad Jacoby é um pioneiro da terapia com células CAR-T pediátricas em Israel. Ele chefia o Centro de Terapia Celular Pediátrica no Sheba Medical Center. O Dr. Jacoby é especializado no tratamento de leucemias e linfomas pediátricos recorrentes e de alto risco. Ele completou bolsas de estudo na Johns Hopkins e no Instituto Nacional do Câncer dos EUA.

• Diretor médico do Centro de Bioterapia Avançada no Sheba Medical Center.
• Autor de mais de 240 publicações científicas em hemato-oncologia pediátrica.
• Certificado em Pediatria e em Hematologia e Oncologia Pediátrica.
• Lidera a integração da terapia com células CAR-T com o transplante de medula óssea.

O Dr. Alper Karaoglan é professor de neurocirurgia no Hospital Memorial Bodrum. Especializa-se no tratamento de tumores cerebrais, aneurismas e condições da coluna vertebral, como a espondilolistese. Ocupou cargos académicos superiores na Universidade de Maltepe durante mais de 15 anos. O Dr. Karaoglan ganhou o prémio de Melhor Artigo da Sociedade Turca de Neurocirurgia.

• Especializado em adenomas hipofisários, cavernomatoses e malformações arteriovenosas.
• Recebeu o prémio de Estímulo ao Jovem Neurocirurgião da Sociedade Turca de Neurocirurgia.
• Membro da Associação Médica Turca e da Sociedade Turca de Neurocirurgia.
• Trata condições complexas, incluindo a doença de Moyamoya e a craniostenose.

O Dr. Anton Wohl é o Diretor da Unidade de Tumores Cerebrais no Sheba Medical Center. Ele é especializado em neuro-oncologia e cirurgia complexa de tumores cerebrais. Concluiu estágios na Mayo Clinic, nos EUA. O Dr. Wohl trabalha em um hospital classificado em 7º lugar mundial pela Newsweek em 2026. Ele se concentra na remoção de tumores preservando a função neurológica.

• Realiza craniotomia com paciente acordado e cirurgia guiada por fluorescência para proteger a função cerebral.
• Utiliza ressonância magnética intraoperatória e mapeamento cerebral funcional durante procedimentos complexos.
• Autor de vários estudos revisados por pares sobre glioblastoma e terapias inovadoras.
• Possui certificação do conselho israelense e licença médica ativa.

O médico é um neurocirurgião altamente qualificado com vasta experiência em procedimentos cranianos e espinhais complexos. As áreas de foco clínico incluem o tratamento cirúrgico de tumores cerebrais, aneurismas e condições hipofisárias. Além disso, o médico é especializado em cirurgia avançada da coluna vertebral, tratando hérnias lombares, cervicais e dorsais, bem como o tratamento de tumores e fraturas da coluna.

Além dos cuidados cranianos e espinhais, o médico é proficiente em cirurgia de nervos periféricos. Com uma formação abrangente em intervenções neurocirúrgicas, o médico oferece atendimento especializado a pacientes que necessitam de soluções cirúrgicas complexas para condições neurológicas e ortopédicas.

O médico é especializado em procedimentos neurocirúrgicos e ortopédicos avançados, com foco clínico principal em tratamentos microcirúrgicos para hérnias de disco lombares e cervicais. Sua vasta experiência inclui o manejo cirúrgico de escoliose, tumores cerebrais e espinhais, e fraturas vertebrais.

Além disso, o médico possui grande experiência na realização de intervenções complexas para estenose do canal espinhal e espondilolistese lombar, utilizando técnicas de precisão para tratar condições degenerativas da coluna e restaurar a mobilidade dos pacientes.

O médico é especializado em procedimentos avançados da coluna vertebral, com foco clínico principal na cirurgia endoscópica fechada de hérnia de disco lombar. A experiência inclui o tratamento cirúrgico de fraturas complexas da coluna e a realização de técnicas cirúrgicas minimamente invasivas para hérnias cervicais e lombares.

O médico é um especialista com experiência na sua área. Ele dedica-se a prestar cuidados clínicos de alta qualidade e a manter os padrões profissionais na prática médica.

O médico é um radiologista altamente versátil com vasta experiência em uma ampla gama de modalidades de imagem diagnóstica e intervencionista. A proficiência clínica inclui radiologia abdominal, Doppler, obstétrica, mamária, musculoesquelética, pediátrica e neurorradiologia, garantindo suporte diagnóstico abrangente para diversas populações de pacientes.

Além da imagem diagnóstica, o médico é qualificado na realização de procedimentos intervencionistas não vasculares, fornecendo soluções minimamente invasivas para condições clínicas complexas. Essa abordagem multidisciplinar permite precisão diagnóstica exata e intervenção terapêutica eficaz em várias especialidades médicas.